Trial Profile
Clinical Trials Insight: 700034405
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Apr 2009
Price :
$35
*
At a glance
- Drugs KAI 1678 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors KAI Pharmaceuticals
- 11 Jun 2008 New trial record.
- 20 May 2008 Participant enrolment has begun. Reported by KAI Pharmaceuticals in a media release.